Hit enter after type your search item
Chemical World

FDA green-lights lecanemab to treat Alzheimer’s disease

By
/
On January 12, 2023
/
At 11:30 pm
/
In Chemical world
22 Views

The developers list an annual price of $26,500 per patient

You May Also Like
This div height required for enabling the sticky sidebar
Generated by Feedzy